FDA 510(k) FDA class 2 Substantially Equivalent 🇮🇳 India

Sodium Chloride Inhalation Solution, USP 0.9%, 3% & 7%

K Number: K232523 · Decision Apr 10, 2024
Classifications
1
FEI Numbers
189
Registration Numbers
189
Same Product Code
507
Applicant Total
1
Review Days
236

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Sodium Chloride Inhalation Solution, USP 0.9%, 3% & 7%
K Number
K232523
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
868.5630
Medical Specialty
Anesthesiology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Mankind Pharma Limited
Date Received
August 18, 2023
Decision Date
April 10, 2024
Product Code
CAF
Advisory Committee
Anesthesiology
Review Advisory Committee
AN
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
CAF Nebulizer (Direct Patient Interface)

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (CAF), ordered by most recent decision date.

View all